Cyclerion Therapeutics Inc (CYCN)

3.33 +0.01  +0.30% NASDAQ Jan 21, 20:00 USD
View Full Chart
Price Chart
View All CYCN News

News

View All Events

Events

Date Type Description
03/12/2021 Earnings Cyclerion Therapeutics Inc Fourth Quarter Earnings Results for 2020
11/05/2020 Earnings Cyclerion Therapeutics Inc Third Quarter Earnings Results for 2020
08/03/2020 Earnings Cyclerion Therapeutics Inc Second Quarter Earnings Results for 2020
06/16/2020 Misc Cyclerion Therapeutics Inc Annual General Meeting for 2019
05/04/2020 Earnings Cyclerion Therapeutics Inc First Quarter Earnings Results for 2020
03/12/2020 Earnings Cyclerion Therapeutics Inc Fourth Quarter Earnings Results for 2019
03/12/2020 Misc Cyclerion Therapeutics Inc Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.cyclerion.com
  • Investor Relations URL: N/A
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Mar. 12, 2021
  • Last Earnings Release: Nov. 05, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.